News Analysis - Pharmaceutical Executive

ADVERTISEMENT

News Analysis
The latest business, scientific & regulatory news from the pharmaceutical and biotechnology industries.

FDA Extends Deadline for Avastin Review

September 21, 2010

September 21, 2010.

Roche Plans Business Makeover

September 8, 2010

September 08, 2010.

Actos Deemed as Safe as Avandia

August 25, 2010

Results from a new study reveal that patients taking Takeda's diabetes treatment Actos have the same rate and kind of side effects as GSK's embattled Avandia. Is this a good sign?

Lilly Kills Two Alzheimer's Trials

August 18, 2010

In a huge blow to Eli Lilly's Alzheimer's pipeline, the drug giant was forced to end two clinical trials due to the fact that the treatment was actually making patients' memory recall worse.

Amgen Head and Neck Cancer Study: A Disappointment

August 11, 2010

Head-and-neck cancer treatment trial flops in Phase 3 trials causing Amgen stock to drop. The first-line therapy failed first and secondary goals compared with chemotherapy alone.

NicOx Shutters HQ After Approval Fail

August 4, 2010

In the wake of FDA's refusal to approve the lead drug in NicOx's pipeline, the French firm has decided to close its US headquarters.

5 Years Later: Conatus Acquires Idun

August 2, 2010

Former Idun Pharma team buys back company from Pfizer.

Sanofi Fights FDA Approval of Generic Lovenox

July 30, 2010

August 2, 2010.

GSK Rethinks Rep Compensation

July 28, 2010

Bonuses for reps at GlaxoSmithKline will soon be based on customer feedback and adherence to company policy, not sales targets. The move promises to transform sales & marketing, but the company offered few details about how the plan will be implemented.

ADVERTISEMENT

Click here